VARIABILITY AND COMPARISON OF SERUM AND PLASMA FIBROBLAST GROWTH FACTOR-23 (FGF-23) LEVELS IN HAEMODIALYSIS PATIENTS

被引：0
|
作者：
Damasiewicz, M. [1 ,2 ]
Kerr, P. [1 ,2 ]
Lu, Z. [2 ,3 ]
Tudball, R. [3 ]
Polkinghorne, K. [1 ,2 ]
机构：
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
[3] Monash Med Ctr, Monash Pathol, Clayton, Vic 3168, Australia
来源：
NEPHROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
018
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
    Nasrallah, Mohamed M.
    El-Shehaby, Amal R.
    Salem, Mona M.
    Osman, Noha A.
    El Sheikh, Esam
    El Din, Usama A. A. Sharaf
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) : 2679 - 2685
  • [2] The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
    Damasiewicz, Matthew J.
    Lu, Zhong X.
    Kerr, Peter G.
    Polkinghorne, Kevan R.
    BMC NEPHROLOGY, 2018, 19
  • [3] The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
    Matthew J. Damasiewicz
    Zhong X. Lu
    Peter G. Kerr
    Kevan R. Polkinghorne
    BMC Nephrology, 19
  • [4] FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions
    Ivey-Miranda, Juan B.
    Stewart, Brendan
    Cox, Zachary L.
    McCallum, Wendy
    Maulion, Christopher
    Gleason, Olyvia
    Meegan, Grace
    Amatruda, Jonathan G.
    Moreno-Villagomez, Julieta
    Mahoney, Devin
    Turner, Jeffrey M.
    Wilson, F. Perry
    Estrella, Michelle M.
    Shlipak, Michael G.
    Rao, Veena S.
    Testani, Jeffrey M.
    CIRCULATION-HEART FAILURE, 2021, 14 (11) : E008385
  • [5] Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    Ibrahim, Salwa
    Rashed, Laila
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (01) : 163 - 169
  • [6] Determinants of serum fibroblast growth factor-23 (FGF-23) in chronic kidney disease
    Manghat, P.
    Cheung, J.
    MacDonald, D.
    Asgari, E.
    Goldsmith, D. J. A.
    Wierzbicki, A. S.
    Fogelman, I.
    Hampson, G.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 83 (01) : 21 - 21
  • [7] Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    Salwa Ibrahim
    Laila Rashed
    International Urology and Nephrology, 2009, 41 : 163 - 169
  • [8] Serum Fibroblast Growth Factor-23 (FGF-23) and Fracture Risk in Elderly Men
    Mirza, Majd Ai
    Karlsson, Magnus K.
    Mellstrom, Dan
    Orwoll, Eric
    Ohlsson, Claes
    Ljunggren, Osten
    Larsson, Tobias E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (04) : 857 - 864
  • [9] Increased serum fibroblast growth factor-23 (FGF-23) and bone turnover in patients with osteoarthritis of knee
    Zhou, Wu
    Liu, Guo-Hui
    Yang, Shu-Hua
    Ye, Shu-Nan
    Wang, Jing
    Liu, Xian-Zhe
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1630 - 1638
  • [10] Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
    Kirkpantur, Alper
    Balci, Mustafa
    Gurbuz, Oguz Alp
    Afsar, Baris
    Canbakan, Basol
    Akdemir, Ramazan
    Ayli, Mehmet Deniz
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1346 - 1354
12345